Cross Country Healthcare Proxy Statement Filed

TL;DR

CCH proxy materials out - shareholders get the scoop from John A. Ma.

AI Summary

Cross Country Healthcare, Inc. filed a DEFA14A on December 4, 2024, containing proxy materials. The filing includes an email and FAQs sent by John A. Ma, indicating communication with shareholders regarding company matters. The company is based in Boca Raton, FL, and operates in the healthcare staffing services sector.

Why It Matters

This filing provides shareholders with essential information for upcoming votes and decisions, ensuring transparency and participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing (DEFA14A) and does not contain new financial information or significant corporate actions that would inherently increase risk.

Key Players & Entities

• CROSS COUNTRY HEALTHCARE INC (company) — Registrant
• John A. Ma (person) — Sender of email and FAQs
• Boca Raton, FL (location) — Company Headquarters
• 7363 (industry_code) — Standard Industrial Classification for Help Supply Services

FAQ

Key Financial Figures

• $18.61 — rd will be automatically converted into $18.61/share in cash, subject to and in accord

Filing Documents

• dp221642_defa14a-1corporate.htm (DEFA14A) — 93KB
• image_003.jpg (GRAPHIC) — 3KB
• image_004.jpg (GRAPHIC) — 3KB
• 0000950103-24-017278.txt ( ) — 103KB

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant  Filed by a Party other than the Registrant  Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to § 240.14a-12 CROSS COUNTRY HEALTHCARE, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. The following email and FAQs were sent by John A. Martins, President and Chief Executive Officer of Cross Country Healthcare, Inc. (“Cross Country”), to employees of Cross Country on December 4, 2024 in connection with the proposed acquisition of Cross Country by Aya Healthcare, Inc. Dear Cross Country Team, We are thrilled to share some exciting news. This morning, we announced that we have entered into an agreement for Cross Country to be acquired by Aya Healthcare. You can read the press release on the Investor Relations page of our website at https://ir.crosscountryhealthcare.com/press-releases . As many of you know, Aya is a leading healthcare talent software and staffing company based in San Diego. The clinical services we provide in clinical and non-clinical settings, including in schools and homes, as well as our Intellify TM workforce platform will complement Aya’s existing capabilities. Together, we will be able to offer customers tech-enabled workforce solutions across the continuum of care, reduce costs and deliver high clinical outcomes for patients. Importantly, we expect the transaction to provide a wider array of opportunities and efficiencies for our healthcare clinicians and create new opportunities for our employees as part of an industry leader with a complementary footprint and offering. Aya shares our commitment to the core values that drive how we conduct our business, treat our employees and serve our customers, and this same focus will guide our actions as we combine our two companies. In terms of next steps, we expect the transaction to close in the first half of 2025, subject to the approval of Cross Country stockholders and other customary closing conditions. Until then, we will continue to operate as separate, independent companies and continue to compete against one other, consistent with business as usual . Our antitrust and other policies will remain in full force and effect until we close the transaction. When we close the transaction, we expect much will stay the same, except as a private company. Cross Country will continue to operate under our own brand after the closing, and I will continue to serve as President and CEO of Cross Country. We expect employees of both companies will benefit from shared best practices, with great opportunities for your personal growth. We will keep you informed as we move forward. In the meantime, we understand that you may have questions and I encourage you to review the attached FAQ document. Please join me for a Town Hall meeting later today at 11:30 AM ET where we will share more about what the next several weeks and months will look like. You will receive an invite to the Town Hall shortly. Cross Country Healthcare, Inc. 6551 Park of Commerce Blvd., Boca Raton, FL 33487 (800) 347.2264 | crosscountry.com I remain incredibly optimistic about what the future of Cross Country holds as a part of Aya. Thank you for your dedication and unwavering commitment. We look forward to embarking on this exciting new chapter together! Respectfully, John A. Martins Cross Country President and CEO If you receive inquiries from media and other external parties, please direct them to our outside public relations agency, Collected Strategies, at CrossCountry-CS@collectedstrategies.com . Please direct inquiries from investors and analysts to Josh Vogel at jvogel@crosscountry.com . Please refrain from discussing the proposed transaction on social media. Important Information and Where to Find It This communication relates to a proposed transaction between Cross Country Healthcare, Inc. (“ Cross Country ”) and Aya Healthcare, Inc. (“ Aya ”) and certain wholly owned subsidiaries of Aya. In connection with this proposed transaction, Cross Country will file a proxy statement on Schedule 14A or other documents with the SEC. This communication is not a substitute for any proxy statement or other document that Cross Country may file with the SEC in connection with the proposed transaction. INVESTORS AND SECURITY

View Full Filing

View this DEFA14A filing on SEC EDGAR